- Home
- KRRO vs RAPT Comparison
KRRO vs RAPT Comparison
Compare KRRO & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- RAPT
- Stock Information
- Founded
- KRRO 2014
- RAPT 2015
- Country
- KRRO United States
- RAPT United States
- Employees
- KRRO N/A
- RAPT N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- KRRO Health Care
- RAPT Health Care
- Exchange
- KRRO Nasdaq
- RAPT Nasdaq
- Market Cap
- KRRO 125.4M
- RAPT 122.9M
- IPO Year
- KRRO 2019
- RAPT 2019
- Fundamental
- Price
- KRRO $15.07
- RAPT $10.68
- Analyst Decision
- KRRO Strong Buy
- RAPT Buy
- Analyst Count
- KRRO 7
- RAPT 5
- Target Price
- KRRO $85.67
- RAPT $32.20
- AVG Volume (30 Days)
- KRRO 122.8K
- RAPT 100.1K
- Earning Date
- KRRO 08-12-2025
- RAPT 08-11-2025
- Dividend Yield
- KRRO N/A
- RAPT N/A
- EPS Growth
- KRRO N/A
- RAPT N/A
- EPS
- KRRO N/A
- RAPT N/A
- Revenue
- KRRO $4,821,000.00
- RAPT N/A
- Revenue This Year
- KRRO $65.08
- RAPT N/A
- Revenue Next Year
- KRRO N/A
- RAPT N/A
- P/E Ratio
- KRRO N/A
- RAPT N/A
- Revenue Growth
- KRRO N/A
- RAPT N/A
- 52 Week Low
- KRRO $10.29
- RAPT $5.67
- 52 Week High
- KRRO $98.00
- RAPT $26.56
- Technical
- Relative Strength Index (RSI)
- KRRO 48.70
- RAPT 52.28
- Support Level
- KRRO $13.34
- RAPT $10.10
- Resistance Level
- KRRO $16.77
- RAPT $13.50
- Average True Range (ATR)
- KRRO 1.46
- RAPT 1.04
- MACD
- KRRO -0.05
- RAPT -0.21
- Stochastic Oscillator
- KRRO 28.68
- RAPT 20.71
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.